IBB PAS Repository

Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different?

Węgrzyn, Grzegorz and Jakóbkiewicz-Banecka, Joanna and Narajczyk, Magdalena and Wiśniewiski, Andrzej and Piotrowska, Ewa and Gabig-Cimińska, Magdalena and Kloska, Anna and Słomińska-Wojewódzka, Monika and Korzon-Burakowska, Anna and Węgrzyn, Alicja (2010) Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different? Medical Hypotheses, 75 . pp. 605-609.

This is the latest version of this item.

[img] PDF - Published Version
Restricted to Registered users only

295kB
[img] HTML
297kB
[img] Microsoft Word
124kB

Abstract

Mucopolysaccharidoses (MPS) are inherited metabolic disorders from the group of lysosomal storage diseases (LSD). They arise from mutations causing dysfunction of one of enzymes involved in degradation of glycosaminoglycans (GAGs) in lysosomes. Impaired degradation of these compounds results in their accumulation in cells and dysfunction of most tissues and organs of patients. If heparan sulfate (HS) is the sole or one of stored GAGs, brain functions are also affected. However, despite the fact that products of incomplete degradation of the same chemical, HS, are accumulated in brains of patients suffering from Hurler disease (MPS type I), Hunter disease (MPS type II), Sanfilippo disease (MPS type III) and Sly disease (MPS type VII), and obvious deterioration of brain functions occur in these patients, their behavior is considerably different between various types of MPS. Here we asked the question about biochemical reasons of these differences. We performed theoretical analysis of products of incomplete HS degradation that accumulate in tissues of patients diagnosed for these diseases. A correlation between chemical structures of incompletely degraded HS and behaviors of patients suffering from particular MPS types was found. We propose a hypothesis that particular chemical moieties occurring at the ends of incompletely degraded HS molecules may determine characteristic behavioral disturbances, perhaps due to chemical reactions interfering with functions of neurons in the brain. A possible experimental testing of this hypothesis is also proposed. If the hypothesis is true, it might shed some new light on biochemical mechanisms of behavioral problems occurring not only in MPS but also in some other diseases.

Item Type:Article
Subjects:Q Science > Q Science (General)
Q Science > QH Natural history > QH301 Biology
Q Science > QH Natural history > QH426 Genetics
R Medicine > R Medicine (General)
R Medicine > RM Therapeutics. Pharmacology
Divisions:Laboratory of Molecular Biology (in Gdansk)
ID Code:255
Deposited By: Prof. Magdalena Gabig-Cimińska
Deposited On:03 Jan 2013 08:48
Last Modified:09 Jan 2013 09:44

Available Versions of this Item

Repository Staff Only: item control page